Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

NCT07262762 · Recruiting

Last updated 2026-05-28

This clinical trial is testing the safety and effectiveness of the medication Tirzepatide (Spartina®) in adults who are overweight or have obesity.

Status Recruiting Currently enrolling participants.

Type Observational

Participants 175 people Planned (estimated).

Who can join Ages 18+ · all sexes

Timeline Started 2025-11 · est. completion 2026-04

Where 14 sites · Iran

What this study is testing ClinicalTrials.gov NCT07262762 ↗

Description as written by the study sponsor.

The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight? 2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight? In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)

Main thing measured	Proportion of patients with ≥5% weight loss
Sponsor	Cinnagen
Conditions studied	Obesity & Overweight
GLP-1 drugs	tirzepatide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07262762 ↗